Search

Methods. Forty-nine dogs with spontaneously occurring osteosarcoma underwent limb-sparing surgery after preoperative therapy consisting of intra-arterial cisplatin alone or intra-arterial cisplatin in combination with doses of radiation from 20-40 Gy in 10 fractions. All resections were marginal, and the defect was repaired with a cortical allograft. Results. Local tumor control was strongly influenced by the percent necrosis in the excised specimen. Overall, the estimated 1-year local recurrence rate was approximately 32% (by life-table estimate). Dogs with less than 75% necrosis had an estimated 1-year recurrence rate of 65%; those with greater than 75% necrosis had an estimated 1-year recurrence rate of 15% (P = 0.004, by log-rank test). Local recurrence was influenced by the radiation dose. Dogs receiving 28 Gy or less had an estimated 50% 1-year recurrence rate, and those receiving 32 Gy or more had an estimated 8% 1-year recurrence rate (P = 0.03, by log-rank test). Normal host bone more frequently became necrotic at doses of 36 Gy or more. Conclusions. Intra-arterial cisplatin in combination with moderate doses of radiation (32 Gy) can achieve a high percent tumor necrosis while maintaining host bone viability. Survival was limited by distant metastasis but was lengthened by treatment compared with some earlier findings. Cancer 1993; 71:2484-90.

Soft tissue sarcomas (STS) are mesenchymal tumors arising from connective tissue elements and are grouped together based on a common biologic behavior. The most common histologic types include malignant peripheral nerve sheath tumors (schwannoma and neurofibrosarcoma) ''hemangiopericytoma,'' fibrosarcoma, and malignant fibrous histiocytoma. These tumors are relatively slow growing yet locally invasive with a high rate of recurrence following conservative management. Appropriate preoperative planning and aggressive surgical resection often result in long-term remission or cure. Identification and evaluation of resection margins are paramount in appropriate case management. The addition of radiotherapy after surgical resection can aid in remission for incompletely resected masses. Systemic chemotherapy for STS should be considered for high-grade tumors with a moderate metastatic potential. Potential prognostic factors include grade, resection margins, size, location, histologic type, and previous treatment, with grade and margins being the most important. Tumor types classified as STS that differ slightly in their presentation or treatment, including synovial cell sarcoma, rhabdomyosarcoma, liposarcoma, and vaccine-associated STS in cats, are discussed. Soft tissue sarcomas can be a frustrating disease to treat, but adherence to solid surgical oncology principles can greatly increase the odds of good disease control.

Skeletal neoplasms in pet animals are uncommon, but can represent a diagnostic and treatment challenge for the veterinary clinician. Osteosarcoma represents the most common histology of primary bone tumor and although the prognosis after treatment is still gaurded, major strides have been made in the treatment of this disease. Treatment success, however, requires a multidisciplinary approach. Additional histologic types cannot be ignored from the diagnosis of cases presenting as bone neoplasms, and many of these can have excellent long-term prognoses if treated appropriately. This article discusses the presentation, diagnosis, and treatment of skeletal neoplasms in general with a specific emphasis on osteosarcoma.

Preoperative assessment of the cancer patient can be broken down into: (1) What is it? (2) Where is it? and (3) What is the status of the patient? Evaluation of local disease begins with obtaining and interpreting cytologic or histologic (biopsy) samples. Tumor staging involves the assessment of tumor invasion into local tissues, draining lymph nodes, and distant sites, especially the pulmonary parenchyma. Staging is performed with the aid of imaging techniques and special procedures such as lymph node and bone marrow aspiration. Because many veterinary cancer patients are geriatric, examination of physiologic patient status through laboratory and other diagnostic avenues is vital to the appropriate selection and success of therapy. After these questions are answered, appropriate treatment options and an ultimate treatment plan can be formulated. This article describes logical and practical approaches for diagnosis, staging, patient assessment, and treatment planning of the animal presented with tumor disease. With appropriate preoperative assessment, we can offer our patients and clients the best care possible.

The clinicopathologic features of hepatic neoplasms such as hepatocellular adenomas, hepatocellular carcinomas, bile duct carcinomas, alid hepatic carcinoids are presented. The authors also discuss the diagnostic and therapeutic approaches to hepatic neoplasia.

Tremendous change and progress have occurred in the field of oncology over the last several decades. Progression in diagnostic techniques, patient support, adjuvant therapies and surgeon training has allowed the field of surgical oncology to make continued improvements in the human cancer field. Although a relatively young field, veterinary surgical oncology has followed in the progressive footsteps of our human counterparts. This article describes the evolution of this rapidly expanding field of veterinary medicine.